Cargando…
ZAK Inhibitor PLX4720 Promotes Extrusion of Transformed Cells via Cell Competition
Previous studies have revealed that, at the initial step of carcinogenesis, transformed cells are often eliminated from epithelia via cell competition with the surrounding normal cells. In this study, we performed cell competition-based high-throughput screening for chemical compounds using cultured...
Autores principales: | Maruyama, Takeshi, Sasaki, Ayana, Iijima, Sayuri, Ayukawa, Shiyu, Goda, Nobuhito, Tazuru, Keisuke, Hashimoto, Norikazu, Hayashi, Takashi, Kozawa, Kei, Sato, Nanami, Ishikawa, Susumu, Morita, Tomoko, Fujita, Yasuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371749/ https://www.ncbi.nlm.nih.gov/pubmed/32688284 http://dx.doi.org/10.1016/j.isci.2020.101327 |
Ejemplares similares
-
Application of in vivo imaging techniques to monitor therapeutic efficiency of PLX4720 in an experimental model of microsatellite instable colorectal cancer
por: Rohde, Sarah, et al.
Publicado: (2017) -
Selective BRAFV600E Inhibitor PLX4720, Requires TRAIL Assistance to Overcome Oncogenic PIK3CA Resistance
por: Oikonomou, Eftychia, et al.
Publicado: (2011) -
Adaptive up-regulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells
por: Basile, Kevin J., et al.
Publicado: (2011) -
Targeting BRAF(V600E) with PLX4720 Displays Potent Antimigratory and Anti-invasive Activity in Preclinical Models of Human Thyroid Cancer
por: Nucera, Carmelo, et al.
Publicado: (2011) -
Plectin is a novel regulator for apical extrusion of RasV12-transformed cells
por: Kadeer, Ailijiang, et al.
Publicado: (2017)